Poor operational and financial decisions due to lack of data on send‑out volumes, routes, and turnaround times
Definition
Without robust tracking, labs lack reliable data on send‑out specimen flows, test volumes per reference lab, transit times, and failure rates, which undermines decisions about which tests to insource, which couriers to use, and how to negotiate reference lab contracts. Sample tracking and LIS resources emphasize that tracking systems provide centralized data and analytics on sample movements and performance; absence of this data leads to blind spots in management decisions.[3][5][7][8][10]
Key Findings
- Financial Impact: Mispriced or suboptimal reference lab contracts and missed insourcing opportunities can easily cost mid‑size organizations $100,000–$500,000 per year in unnecessary send‑out spend and extended turnaround times impacting downstream costs.
- Frequency: Monthly
- Root Cause: Send‑out activity recorded in manual logs or disparate systems with no consolidated reporting; lack of integration between tracking, LIS, and financial systems; and no consistent KPIs for send‑out turnaround, failure rate, and cost per test.[3][5][8][10]
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Medical and Diagnostic Laboratories.
Affected Stakeholders
Laboratory directors, Service line leaders (e.g., oncology, genetics), Supply chain and contracting teams, Finance and strategy executives
Deep Analysis (Premium)
Financial Impact
$100,000–$500,000 per year in mispriced contracts and missed insourcing opportunities. • $100,000–$500,000/year excess courier and TAT-related costs • $100,000–$500,000/year from client churn due to slow send-outs
Current Workarounds
Custom Excel dashboards populated from reference lab portals and courier logs • Custom SQL queries and Excel pivot tables from LIS • Excel aggregation of billing data and manual TAT tracking via email chains
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
Lost charge capture for send‑out tests due to poor tracking and order/result mismatches
Excess courier, shipping, and labor costs from inefficient send‑out specimen tracking
Lost, misrouted, or compromised send‑out specimens leading to redraws and repeat testing
Delayed billing and extended AR from slow send‑out status visibility
Technologist and coordinator time wasted searching for and reconciling send‑out specimens
Chain-of-custody and traceability deficiencies risking CLIA/ISO nonconformities for send‑outs
Request Deep Analysis
🇺🇸 Be first to access this market's intelligence